Data Safety Monitoring Boards: Their Role in Drug Development and Pharmaceutical Trials

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.17, Iss.1, 2003-01, pp. : 39-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Perspectives on Data Safety Monitoring Boards: Protecting the Integrity of Data

By Hemmings R. Day S.

Drug Safety, Vol. 27, Iss. 1, 2004-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Operational Guidelines for the Establishment and Functioning of Data and Safety Monitoring Boards

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 1, 2006-01 ,pp. : 25-36

Adis International

Access to resources Recommend Favorite

A Review of: “Data and Safety Monitoring Committees in Clinical Trials, by J. Herson”

By Gallo Paul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1168-1171

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts

By Olsson S.

Drug Safety, Vol. 19, Iss. 1, 1998-07 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite

Pharmaceutical development of microbicide drug products

By Friend David R.

Pharmaceutical Development and Technology, Vol. 15, Iss. 6, 2010-12 ,pp. : 562-581

Informa Healthcare

Access to resources Recommend Favorite